Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK DDI Study of Hetrombopag Olamine and Ciclosporin in Healthy Subjects
NCT05088174Phase 1Completed
- Sponsor
- Hengrui
- Start
- Sep 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hetrombopag in aplastic anemia, sponsored by Hengrui. Primary endpoints: Peak Plasma Concentration, Area Under the Curve 0-120h and 1 more. Started Sep 2020; status: completed.
02
Drugs
hetrombopag
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT05088174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05088174.